• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    New insight of vitamin D in chronic liver diseases

    2014-05-04 09:38:13EnQiangChenYingShiandHongTang

    En-Qiang Chen, Ying Shi and Hong Tang

    Chengdu, China

    New insight of vitamin D in chronic liver diseases

    En-Qiang Chen, Ying Shi and Hong Tang

    Chengdu, China

    BACKGROUND:Vitamin D is a fat-soluble sterol derivative that is predominantly synthesized in the liver and has multiple functions. The accumulative data showed that the clinical manifestations and prognosis of chronic liver diseases are associated with serum vitamin D levels.

    DATA SOURCES:A PubMed and Google Scholar search using terms: "vitamin D", "25(OH)D", "liver disease", "viral hepatitis", "non-alcoholic fatty liver disease", "liver fibrosis", "cirrhosis", "hepatocellular carcinoma" and "autoimmune liver disease" was performed, and relevant articles published in English between January 2000 and March 2014 were reviewed. Fulltext publications relevant to the field were selected and relevant articles from reference lists were also included.

    RESULTS:The insufficiency or deficiency of vitamin D is common in various kinds of chronic liver diseases including viral hepatitis B and C. Serum 25-hydroxyvitamin D and vitamin D receptors are possibly interrelated with the incidence, treatment and prognosis of diseases. Though the evidence of vitamin D supplementation in viral hepatitis and associated liver diseases is still limited, there is great potential to apply this adjuvant therapy to improve the treatments.

    CONCLUSIONS:Although the exact role and mechanisms of vitamin D have not been fully elucidated in chronic liver diseases, it is potentially beneficial in the treatment of chronic liver diseases. Further mechanistic studies are needed to validate its clinical application.

    (Hepatobiliary Pancreat Dis Int 2014;13:580-585)

    vitamin D;

    deficiency;

    viral hepatitis;

    chronic liver diseases

    Introduction

    Vitamin D, the sunshine vitamin, is now recognized not only for its importance of bone health in humans,[1]but also for other health benefits including reducing the risk or progression of chronic liver diseases (CLDs). Vitamin D produced in the skin or ingested in the diet is biologically inert and requires two successive hydroxylations first in the liver on carbon 25 to form 25-hydroxyvitamin D [25(OH)D], and then in the kidney for a hydroxylation on carbon 1 to form the most important biologically active form of vitamin D, 1, 25-dihydroxyvitamin D [1, 25(OH)2D].[2]It is worthy to mention that extra renal hydroxylation of 25(OH)D is also important for the non-skeletal actions of vitamin D, because 1, 25(OH)2D controls a variety of genes directly or indirectly to regulate cellular proliferation, differentiation, apoptosis and angiogenesis.[3]

    In the past decades, methods have been developed to measure serum 25(OH)D and 1, 25(OH)2D concentrationsin vivo. In recent years, lots of evidences suggest that serum 25(OH)D is the best indicator of vitamin D statusin vivo;[4]while serum 1, 25(OH)2D provides limited information about vitamin D status, because it is often normal or even elevated due to secondary hyperparathyroidism associated with vitamin D deficiency. So serum 25(OH)D examination now has been widely used to evaluate vitamin D concentrations in clinical practice.[4]

    Clinical and epidemiological data have shown that chronic viral hepatitis and their extrahepatic manifestations are associated with lower vitamin D concentrations.[5]In recent years, there has been considerable speculation about the potential role of vitamin D in the treatment of CLD patients with low serum vitamin D levels.[6,7]It is encouraging that the therapeutic value of vitamin D supplement has been confirmed in autoimmune liver diseases.[8,9]And a recent study[10]also showed the association between vitamin D shortage and the severity of chronic viral hepatitis, non-alcoholic fatty liver disease (NAFLD) and other CLDs. In this review, we briefly summarize thenew progress of factors affecting vitamin D deficiency in common CLDs and the correlation of viral hepatitis and other CLDs with reduced serum 25(OH)D concentrations.

    Factors associated with vitamin D deficiency

    Serum 25(OH)D concentration is an objective variable reflecting vitamin D restoration in body, but there is no exact definition of its normal range in real clinical setting. In general population, the normal concentration of serum 25(OH)D is 75-120 nmol/L (30-50 ng/mL), inadequate concentration is 50-75 nmol/L (20-30 ng/ mL), while shortage concentration is less than 50 nmol/ L (<20 ng/mL); and there is no difference between male and female populations. According to this standard, approximately one billion people worldwide are vitamin D inadequate or shortage.

    Most scholars believe that the lack of sun ultraviolet exposure is the main cause of vitamin D insufficiency, because air pollution induced by modern industry retard the necessary ultraviolet radiation which is essential for vitamin D synthesis.[11]Currently, modern lifestyle habits also play a pivotal role in vitamin D inadequate or shortage. To prevent skin aging or cancer, sun umbrella and sunscreen cosmetics are intentionally utilized to stay away from sunshine. The prolongation of life span is another factor of vitamin D deficiency, vitamin D synthesis in skin and absorption by intestinal tract declines along with increasing age.[11]Additionally, the vitamin D content in modern fortified foods is significantly less than that in wild oily marine fish, freshwater fish, cod liver oil, egg yolk and so on. In recent years, high heritability suggests that genetic factors could also play a role in vitamin D deficiency.[12,13]For example, variants genes involved in cholesterol synthesis, hydroxylation, and vitamin D transport affect vitamin D status; and genetic variation at these loci identifies individuals who have substantially raised risk of vitamin D insufficiency.[12]

    The distribution of the vitamin D in the body also affects the serum levels. Serum 25(OH)D is often decreased in obese people because of the retaining of vitamin D in adipose tissue. The vitamin D retaining capability of the adipose tissue is the same and therefore, the vitamin D is diluted in people with obese, leading to the decrease of serum vitamin D. The weight loss caused by malabsorption may also lower the serum vitamin D level. As there is no feedback regulation of hydroxylation of vitamin D in the liver, when liver parenchyma disease occurs, impaired hydroxylation of vitamin D can also lead to vitamin D deficiency or shortage.[14,15]A genetic study[12]showed that vitamin D related gene polymorphisms, including vitamin D-binding protein (DBP), vitamin D receptor (VDR) and α1 hydroxylase gene, are associated with serum vitamin D concentrations.

    Viral hepatitis

    Clinical evidence indicated that patients with chronic hepatitis C (CHC) are always at higher risk of vitamin D deficiency.[16]In a large scale study,[17]serum 25(OH)D in CHC patients was significantly lower than that in healthy population (25.07±9.92 vs 43.06±10.19 ng/mL, P<0.0001), and serum 25(OH)D was less than 30 ng/mL in 73% of CHC patients whereas only 6% in the healthy controls. Current evidence[17,18]suggested that HCV not only inhibits 25(OH)D synthesis by regulating lipid metabolism, but also decreases the production of previtamin D, which is an intermediate in the cascades of 1, 25(OH)2D synthesis.[19]Low serum 25(OH)D level is associated with the severity of liver diseases and fibrosis damage in CHC patients.[20,21]

    Serum 25(OH)D deficiency is associated with the severity of liver diseases in human immunodeficiency virus (HIV)/HCV co-infected patients,[10,22]and lower serum 25(OH)D may also impair virological response to pegylated interferon α (PEG-IFNα) and ribavirin (RBV) therapy in those HIV/HCV co-infected patients.[23]The low level of serum vitamin D may negatively affect the virological response of PEG-IFNα/ RBV, and appropriate vitamin D supplement would improve sustained virological response in CHC and HIV/ HCV co-infected patients.[22,23]Gal-Tanamy et al[24]suggested that vitamin D inhibits HCV RNA replication directly, possessing natural antiviral activity, and its collaborative antiviral effect with interferon improves antiviral effect in CHC patients.[6,25]Kondo et al[26]reported that 1, 25(OH)2D supplement improves the sensitivity of PEG-IFNα/RBV therapy on HCV-infected hepatocytes by reducing the IP-10 production from PBMCs and ISGs expression in the liver. Additionally, the beneficial effect of vitamin D on decreasing insulin resistance and improving systemic inflammation may also contribute to the virological response of PEGIFNα/RBV therapy in CHC patients.[6,27,28]These data indicate that CHC patients with low serum vitamin D need to supply this vitamin when they are treated with PEG-IFNα/RBV.[29]It is worthy to mention that serum DBP and the polymorphism of DBP are known to influence vitamin D levels; and in difficult-to-treat HCV genotypes, simultaneous pretreatment normal serum vitamin D levels and the carriage of DBP wild-type isoform strongly predicts the achievement of sustained virological response after PEG-IFNα/RBV antiviraltherapy.[30]

    New evidence continues to suggest a relationship between serum vitamin D level and chronic hepatitis B (CHB). Farnik et al[31]quantitatively examined the levels of serum 25(OH)D in 203 untreated CHB patients, and found that there were 34% patients with severe vitamin deficiency (<10 ng/mL), 47% with vitamin D insufficiency, and only 19% with normal level. Whereas vitamin D level in HBeAg positive patients is notably lower than that in HBeAg negative patients. Meanwhile, vitamin D level presents opposite seasonal fluctuations compared with HBV DNA, and the low level of serum 25(OH)D is correlated with high HBV DNA.[31]Though, it is still uncertain whether the low level of serum vitamin D decreases the efficacy of PEG- IFNα or nucleos(t)ide analogs, some scholars speculated that appropriate vitamin D supplement may be helpful to improve or optimize curative efficacy of existing antiviral therapy for CHB patients with vitamin D deficiency. Because of the huge amount of CHB patients all over the world and the relative limited therapeutic drugs and antiviral strategies, it is very important and necessary to recognize the role of vitamin D in CHB progression, and potential value for increasing the antiviral efficacy of existing antiviral therapy and developing new targets for antiviral treatment in the future.

    NAFLD

    The morbidity of NAFLD is on the rise worldwide, and epidemiological data showed that NAFLD morbidity is significantly higher in the vitamin D deficiency population than that in normal subjects; similarly, NAFLD patients tend to have a lower vitamin D level.[32-34]

    Nakano and coworkers[35]reported that in an animal study the lower level of vitamin D is associated with obesity and severity of liver steatosis, indicating that vitamin D deficiency may participate in NAFLD progression. Vitamin D deficiency may also up-regulate hepatic inflammation and oxidative stress genes via endotoxin and Toll-like receptor pathway to cause NAFLD.[36]Considering the significance of insulin resistance in NAFLD development,[37]the correlation between vitamin D deficiency and insulin resistance might be another important cause of the progression of NAFLD, as low vitamin D level is associated with the impaired function of islet beta cells.[38]Interestingly, current preclinical studies demonstrated that sunlight exposure and vitamin D supplements helped to ameliorate NAFLD histopathology. Kitson and Roberts[39]proposed that vitamin D plays an important role in the activation and regulation of both innate and adaptive immune systems, which indicate the beneficial effect of vitamin D on NAFLD. Although the exact mechanism is still not clear, we believe that vitamin D is an effective drug in the prevention and treatment of NAFLD.

    Liver fibrosis and cirrhosis

    Due to the severe liver functional damage, the construction of transport proteins in patients with fibrosis and cirrhosis is decreased. Thus, vitamin D de ficiency is very common in these patients. In HIV/ HCV co-infected patients, serum 25(OH)D levels are signi ficantly correlated with the Metavir fibrosis score; and patients with severe fibrosis (Metavir F3/F4) have lower serum 25(OH)D levels compared with F2 and F1 patients (16.2 ± 10.0 vs 18.9±8.5 and 20.9±11.1 ng/ mL, respectively).[22]In genotype I CHC patients, lower serum vitamin D levels are signi ficantly associated with the severity of liver fibrosis,[17]and correction of vitamin D de ficiency in patients with CLD is a potential therapy to inhibit progression of fibrosis, as 1, 25(OH)2D and its nuclear receptor repress human α1(I) collagen expression and type I collagen formation.[40]Indeed, those clinical findings are also supported by in vitro and in vivo experiments, showing that 1, 25(OH)2D possesses antifibrosis effect both in bone marrow mesenchymal stem cells and fibrosis rat, with the increasing expression of VDR caused by 1, 25(OH)2D, which inhibit the proliferation of hepatic stellate cells and the expression of cyclin D1, tissue inhibitor of metalloproteinase 1 and collagen.[41]In addition, vitamin D is also able to reduce the production of body smooth muscle actin and collagen, thus inhibiting the progression of liver cirrhosis induced by thioacetamide. All those clues strongly suggest that vitamin D is most likely to be an anti-fibrosis agent.[42]

    In the past years, genome-wide studies have identified genetic variants (including DHCR7, CYP2R1 and DBP) that affect serum 25(OH)D levels in healthy populations; and GG homozygosis for DHCR7 gene and lower 25(OH)D levels in CHC patients are both independently associated with the severity of liver fibrosis.[43]Grünhage et al[44]also reported that the common variation in 25(OH)D metabolism is associated with liver stiffness in patients with CLD, and the stronger influence of 25(OH)D is on the initiation rather than progression of hepatic fibrosis. Moreover, the low level of VDR is also an important factor affecting fibrosis,[45]and VDR gene polymorphism is significantly linked with fibrosis and cirrhosis progression,[46]including the presence of cirrhosis in CHC patients.[21]

    Hepatocellular carcinoma

    Hepatocellular carcinoma (HCC) is the sixth mostcommon cancer in the world, approximately 630 000 new cases are diagnosed each year. Amany them, 82% of the cases are related to viral hepatitis, 55% to HBV; but 89% of the cases are in regions where HBV is endemic.[47]

    There is a correlation between the progressive decline of active vitamin D and the progression of liver disease. Genetic analyses also revealed a role for vitamin D insufficiency in HCV-associated HCC development.[48]Thus, some researchers[49]proposed that serum vitamin D is also a potential biomarker of HCC, just like serum α-fetoprotein, and that vitamin D may be valuable for monitoring HCC in patients with high-risk, including those with CHB or CHC. In addition, vitamin D deficiency is common in HCC patients after liver transplantation and is closely related to prognosis, thus serum vitamin D levels also may be a prognostic indicator for HCC after treatment, and vitamin D supplementation may help to prevent acute cellular rejection in liver recipients with severe vitamin D deficiency.

    Though current epidemiological data are not enough to completely uncover the correlation between vitamin D and HCC, lots of experimental evidences suggested that vitamin D and its analogs (such as EB1089 and seocalcitol) have inhibitory effect against HCC cell lines.[50-52]Active 1, 25(OH)2D has anti-tumor effects in several aspects, including anti-proliferation, antiinflammatory, anti-angiogenesis, promoting apoptosis and differentiation.[51,53,54]Moreover, DBP-macrophage activating factor activates macrophages, the latter has anti-angiogenic activity and tumor killing activity, which inhibit HCC growth.[55]All of the data above implied that vitamin D and vitamin D-related molecules may represent a new strategy for the treatment of HCC.

    Autoimmune liver disease

    The development of autoimmune disease is based on the interaction of genetic susceptibility and environmental causes. Vitamin D endocrine system plays important roles in host immune system responses. For example, activated macrophages (a type of immune cell) not only produce 1, 25(OH)2D, but also express VDR.[56]And the liverproduced 1, 25(OH)2D could further activate a negative feed-back loop at sites of inflammation and therefore contribute to the suppression of the occurrence of autoimmune liver disease.[56]

    Actually, the active vitamin D acts its biological effects by binding to its own receptor VDR; and vitamin D also modulates the expression of VDR in human bile duct epithelial cells. D'Aldebert et al[57]demonstrated that biliary epithelial cells in human liver expressed both cathelicidin and VDR, and that VDR is also an important nuclear receptor for ursodeoxycholic acid (UDCA) inducing cathelicidin expression in biliary epithelial cells. Thus the hepatic expression of VDR increased the efficacy of UDCA therapy, and vitamin D and UDCA have synergistic effect on some autoimmune liver diseases such as primary biliary cirrhosis and primary sclerosing cholangitis.

    Recent studies[58,59]found that genetic factors appear to be involved in the pathogenesis of autoimmune liver diseases, and that VDR polymorphisms may be associated with autoimmune liver diseases such as autoimmune hepatitis and primary biliary cirrhosis. However, further studies are still needed to elucidate the mechanisms by which VDR polymorphisms contribute to the losing of immune tolerance in autoimmune diseases.

    Summary

    Vitamin D, along with its related VDR, is possibly interrelated with the incidence, treatment and prognosis of a variety of chronic liver diseases. Though the exact role and mechanisms of vitamin D in viral hepatitis have not been fully elucidated and the evidence for vitamin D supplement in those populations is still limited, vitamin D supplement may potentially optimize the current treatment. The role of vitamin D in CLD needs further study.

    Contributors:TH proposed the study. CEQ and SY performed research and wrote the first draft. CEQ collected and analyzed the data. All authors contributed to the design and interpretation of the study and to further drafts. TH is the guarantor.

    Funding:This study was supported by grants from the National Twelve-Five Project of China (2012ZX10002007-001-003), and the Chinese Foundation for Hepatitis Prevention and Control-TianQing Liver Disease Research Fund (cfhpc20132047).

    Ethical approval:Not needed.

    Competing interest:No benefits in any form have been received or will be received from a commercial party related directly or indirectly to the subject of this article.

    1 Wacker M, Holick MF. Sunlight and Vitamin D: A global perspective for health. Dermatoendocrinol 2013;5:51-108.

    2 Holick MF. Vitamin D: evolutionary, physiological and health perspectives. Curr Drug Targets 2011;12:4-18.

    3 Nagpal S, Na S, Rathnachalam R. Noncalcemic actions of vitamin D receptor ligands. Endocr Rev 2005;26:662-687.

    4 Health Quality Ontario. Clinical utility of vitamin d testing: an evidence-based analysis. Ont Health Technol Assess Ser 2010;10:1-93.

    5 Arteh J, Narra S, Nair S. Prevalence of vitamin D deficiency in chronic liver disease. Dig Dis Sci 2010;55:2624-2628.

    6 Bitetto D, Fabris C, Fornasiere E, Pipan C, Fumolo E, Cussigh A, et al. Vitamin D supplementation improves response to antiviral treatment for recurrent hepatitis C. Transpl Int 2011;24:43-50.

    7 Han YP, Kong M, Zheng S, Ren Y, Zhu L, Shi H, et al. Vitamin D in liver diseases: from mechanisms to clinical trials. J Gastroenterol Hepatol 2013;28:49-55.

    8 Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 2004;80:1678S-1688S.

    9 Smyk DS, Orfanidou T, Invernizzi P, Bogdanos DP, Lenzi M. Vitamin D in autoimmune liver disease. Clin Res Hepatol Gastroenterol 2013;37:535-545.

    10 Guzmán-Fulgencio M, García-álvarez M, Berenguer J, Jiménez-Sousa Má, Cosín J, Pineda-Tenor D, et al. Vitamin D deficiency is associated with severity of liver disease in HIV/ HCV coinfected patients. J Infect 2014;68:176-184.

    11 Tsiaras WG, Weinstock MA. Factors influencing vitamin D status. Acta Derm Venereol 2011;91:115-124.

    12 Wang TJ, Zhang F, Richards JB, Kestenbaum B, van Meurs JB, Berry D, et al. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet 2010;376:180-188.

    13 Ahn J, Yu K, Stolzenberg-Solomon R, Simon KC, McCullough ML, Gallicchio L, et al. Genome-wide association study of circulating vitamin D levels. Hum Mol Genet 2010;19:2739-2745.

    14 Stokes CS, Volmer DA, Grünhage F, Lammert F. Vitamin D in chronic liver disease. Liver Int 2013;33:338-352.

    15 Nair S. Vitamin d deficiency and liver disease. Gastroenterol Hepatol (N Y) 2010;6:491-493.

    17 Petta S, Cammà C, Scazzone C, Tripodo C, Di Marco V, Bono A, et al. Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C. Hepatology 2010;51:1158-1167.

    18 Clark PJ, Thompson AJ, Vock DM, Kratz LE, Tolun AA, Muir AJ, et al. Hepatitis C virus selectively perturbs the distal cholesterol synthesis pathway in a genotype-specific manner. Hepatology 2012;56:49-56.

    19 Webb AR. Who, what, where and when-influences on cutaneous vitamin D synthesis. Prog Biophys Mol Biol 2006;92:17-25.

    20 El Husseiny NM, Fahmy HM, Mohamed WA, Amin HH. Relationship between vitamin D and IL-23, IL-17 and macrophage chemoattractant protein-1 as markers of fibrosis in hepatitis C virus Egyptians. World J Hepatol 2012;4:242-247.

    21 Baur K, Mertens JC, Schmitt J, Iwata R, Stieger B, Eloranta JJ, et al. Combined effect of 25-OH vitamin D plasma levels and genetic vitamin D receptor (NR 1I1) variants on fibrosis progression rate in HCV patients. Liver Int 2012;32:635-643.

    22 Terrier B, Carrat F, Geri G, Pol S, Piroth L, Halfon P, et al. Low 25-OH vitamin D serum levels correlate with severe fibrosis in HIV-HCV co-infected patients with chronic hepatitis. J Hepatol 2011;55:756-761.

    23 Mandorfer M, Reiberger T, Payer BA, Ferlitsch A, Breitenecker F, Aichelburg MC, et al. Low vitamin D levels are associated with impaired virologic response to PEGIFN + RBV therapy in HIV-hepatitis C virus coinfected patients. AIDS 2013;27:227-232.

    24 Gal-Tanamy M, Bachmetov L, Ravid A, Koren R, Erman A, Tur-Kaspa R, et al. Vitamin D: an innate antiviral agent suppressing hepatitis C virus in human hepatocytes. Hepatology 2011;54:1570-1579.

    25 Petta S, Ferraro D, Cammà C, Cabibi D, Di Cristina A, Di Marco V, et al. Vitamin D levels and IL28B polymorphisms are related to rapid virological response to standard of care in genotype 1 chronic hepatitis C. Antivir Ther 2012;17:823-831.

    26 Kondo Y, Kato T, Kimura O, Iwata T, Ninomiya M, Kakazu E, et al. 1(OH) vitamin D3 supplementation improves the sensitivity of the immune-response during Peg-IFN/RBV therapy in chronic hepatitis C patients-case controlled trial. PLoS One 2013;8:e63672.

    27 Abu-Mouch S, Fireman Z, Jarchovsky J, Zeina AR, Assy N. Vitamin D supplementation improves sustained virologic response in chronic hepatitis C (genotype 1)-na?ve patients. World J Gastroenterol 2011;17:5184-5190.

    28 Nimer A, Mouch A. Vitamin D improves viral response in hepatitis C genotype 2-3 na?ve patients. World J Gastroenterol 2012;18:800-805.

    29 Rahman AH, Branch AD. Vitamin D for your patients with chronic hepatitis C? J Hepatol 2013;58:184-189.

    30 Falleti E, Bitetto D, Fabris C, Fattovich G, Cussigh A, Cmet S, et al. Vitamin D binding protein gene polymorphisms and baseline vitamin D levels as predictors of antiviral response in chronic hepatitis C. Hepatology 2012;56:1641-1650.

    30 Farnik H, Bojunga J, Berger A, Allwinn R, Waidmann O, Kronenberger B, et al. Low vitamin D serum concentration is associated with high levels of hepatitis B virus replication in chronically infected patients. Hepatology 2013;58:1270-1276.

    32 Targher G, Scorletti E, Mantovani A, Byrne CD. Nonalcoholic fatty liver disease and reduced serum vitamin D(3) levels. Metab Syndr Relat Disord 2013;11:217-228.

    33 Eliades M, Spyrou E, Agrawal N, Lazo M, Brancati FL, Potter JJ, et al. Meta-analysis: vitamin D and non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2013;38:246-254.

    34 Jablonski KL, Jovanovich A, Holmen J, Targher G, McFann K, Kendrick J, et al. Low 25-hydroxyvitamin D level is independently associated with non-alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis 2013;23:792-798.

    35 Nakano T, Cheng YF, Lai CY, Hsu LW, Chang YC, Deng JY, et al. Impact of artificial sunlight therapy on the progress of non-alcoholic fatty liver disease in rats. J Hepatol 2011;55:415-425.

    36 Roth CL, Elfers CT, Figlewicz DP, Melhorn SJ, Morton GJ, Hoofnagle A, et al. Vitamin D deficiency in obese rats exacerbates nonalcoholic fatty liver disease and increases hepatic resistin and Toll-like receptor activation. Hepatology 2012;55:1103-1111.

    37 Bugianesi E, Moscatiello S, Ciaravella MF, Marchesini G. Insulin resistance in nonalcoholic fatty liver disease. Curr Pharm Des 2010;16:1941-1951.

    38 Kayaniyil S, Retnakaran R, Harris SB, Vieth R, Knight JA, Gerstein HC, et al. Prospective associations of vitamin D with β-cell function and glycemia: the PROspective Metabolism and ISlet cell Evaluation (PROMISE) cohort study. Diabetes2011;60:2947-2953.

    39 Kitson MT, Roberts SK. D-livering the message: the importance of vitamin D status in chronic liver disease. J Hepatol 2012;57:897-909.

    40 Potter JJ, Liu X, Koteish A, Mezey E. 1,25-dihydroxyvitamin D3 and its nuclear receptor repress human α1 (I) collagen expression and type I collagen formation. Liver Int 2013;33: 677-686.

    41 Abramovitch S, Dahan-Bachar L, Sharvit E, Weisman Y, Ben Tov A, Brazowski E, et al. Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats. Gut 2011;60:1728-1737.

    42 Song BJ, Rockey DC. Status of research on vitamin D supplementation in treating or preventing liver fibrosis. Liver Int 2013;33:653-655.

    43 Petta S, Grimaudo S, Marco VD, Scazzone C, Macaluso FS, Cammà C, et al. Association of vitamin D serum levels and its common genetic determinants, with severity of liver fibrosis in genotype 1 chronic hepatitis C patients. J Viral Hepat 2013;20:486-493.

    44 Grünhage F, Hochrath K, Krawczyk M, H?blinger A, Obermayer-Pietsch B, Geisel J, et al. Common genetic variation in vitamin D metabolism is associated with liver stiffness. Hepatology 2012;56:1883-1891.

    45 Ding N, Yu RT, Subramaniam N, Sherman MH, Wilson C, Rao R, et al. A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response. Cell 2013;153:601-613.

    46 Tanaka A, Nezu S, Uegaki S, Kikuchi K, Shibuya A, Miyakawa H, et al. Vitamin D receptor polymorphisms are associated with increased susceptibility to primary biliary cirrhosis in Japanese and Italian populations. J Hepatol 2009;50:1202-1209.

    47 Michielsen P, Ho E. Viral hepatitis B and hepatocellular carcinoma. Acta Gastroenterol Belg 2011;74:4-8.

    48 Lange CM, Miki D, Ochi H, Nischalke HD, Bojunga J, Bibert S, et al. Genetic analyses reveal a role for vitamin D insufficiency in HCV-associated hepatocellular carcinoma development. PLoS One 2013;8:e64053.

    49 Hammad LN, Abdelraouf SM, Hassanein FS, Mohamed WA, Schaalan MF. Circulating IL-6, IL-17 and vitamin D in hepatocellular carcinoma: potential biomarkers for a more favorable prognosis? J Immunotoxicol 2013;10:380-386.

    50 Ghous Z, Akhter J, Pourgholami MH, Morris DL. Inhibition of hepatocellular cancer by EB1089: in vitro and in vive study. Anticancer Res 2008;28:3757-3761.

    51 Chiang KC, Yeh CN, Chen MF, Chen TC. Hepatocellular carcinoma and vitamin D: a review. J Gastroenterol Hepatol 2011;26:1597-1603.

    52 Dalhoff K, Dancey J, Astrup L, Skovsgaard T, Hamberg KJ, Lofts FJ, et al. A phase II study of the vitamin D analogue Seocalcitol in patients with inoperable hepatocellular carcinoma. Br J Cancer 2003;89:252-257.

    53 Guo J, Ma Z, Ma Q, Wu Z, Fan P, Zhou X, et al. 1, 25(OH)2D3inhibits hepatocellular carcinoma development through reducing secretion of inflammatory cytokines from immunocytes. Curr Med Chem 2013;20:4131-4141.

    54 Fingas CD, Altinbas A, Schlattjan M, Beilfuss A, Sowa JP, Sydor S, et al. Expression of apoptosis- and vitamin D pathway-related genes in hepatocellular carcinoma. Digestion 2013;87:176-181.

    55 Nonaka K, Onizuka S, Ishibashi H, Uto Y, Hori H, Nakayama T, et al. Vitamin D binding protein-macrophage activating factor inhibits HCC in SCID mice. J Surg Res 2012;172:116-122.

    56 Hayes CE, Nashold FE, Spach KM, Pedersen LB. The immunological functions of the vitamin D endocrine system. Cell Mol Biol (Noisy-le-grand) 2003;49:277-300.

    57 D'Aldebert E, Biyeyeme Bi Mve MJ, Mergey M, Wendum D, Firrincieli D, Coilly A, et al. Bile salts control the antimicrobial peptide cathelicidin through nuclear receptors in the human biliary epithelium. Gastroenterology 2009;136: 1435-1443.

    58 Vogel A, Strassburg CP, Manns MP. Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis. Hepatology 2002;35:126-131.

    59 Fan L, Tu X, Zhu Y, Zhou L, Pfeiffer T, Feltens R, et al. Genetic association of vitamin D receptor polymorphisms with autoimmune hepatitis and primary biliary cirrhosis in the Chinese. J Gastroenterol Hepatol 2005;20:249-255.

    Received March 27, 2014

    Accepted after revision June 30, 2014

    Author Affiliations: Center of Infectious Diseases, West China Hospital; and Division of Infectious Diseases, State Key Laboratory of Biotherapy, Sichuan University, Chengdu 610041, China (Chen EQ, Shi Y and Tang H)

    Hong Tang, MD, PhD, Center of Infectious Diseases, West China Hospital; and Division of Infectious Diseases, State Key Laboratory of Biotherapy, Sichuan University, Chengdu 610041, China (Tel: +86-28-85422650; Fax: +86-28-85423052; Email: htang6198@hotmail. com)

    ? 2014, Hepatobiliary Pancreat Dis Int. All rights reserved.

    10.1016/S1499-3872(14)60295-2

    Published online August 21, 2014.

    韩国av在线不卡| 亚洲精品粉嫩美女一区| 午夜免费男女啪啪视频观看 | av免费在线看不卡| 日本三级黄在线观看| 免费大片18禁| 午夜福利在线观看免费完整高清在 | 91精品国产九色| 久久久精品94久久精品| 久久精品91蜜桃| 久久久久久久亚洲中文字幕| 久久午夜福利片| 久久国产乱子免费精品| 国产精品不卡视频一区二区| 乱系列少妇在线播放| 国产精品一区二区三区四区久久| 亚洲在线观看片| 男插女下体视频免费在线播放| 菩萨蛮人人尽说江南好唐韦庄 | 久久久精品94久久精品| 老熟妇仑乱视频hdxx| 精品久久久久久久久久免费视频| 国产成人a∨麻豆精品| 精品久久久久久久久亚洲| 色5月婷婷丁香| 三级毛片av免费| a级毛片免费高清观看在线播放| 亚洲成av人片在线播放无| 国产色婷婷99| 日韩欧美一区二区三区在线观看| 国产探花在线观看一区二区| 99在线视频只有这里精品首页| 亚州av有码| 国产视频一区二区在线看| 老女人水多毛片| av视频在线观看入口| 欧美日韩综合久久久久久| 99在线视频只有这里精品首页| 老熟妇乱子伦视频在线观看| 免费看av在线观看网站| 深爱激情五月婷婷| 精品不卡国产一区二区三区| 久久久久精品国产欧美久久久| 日韩欧美精品免费久久| 精品一区二区免费观看| av福利片在线观看| 少妇熟女欧美另类| 一级毛片电影观看 | av黄色大香蕉| 成人无遮挡网站| 丰满的人妻完整版| 精品不卡国产一区二区三区| 十八禁国产超污无遮挡网站| 毛片女人毛片| 国产精品人妻久久久影院| 成年女人看的毛片在线观看| 99热精品在线国产| aaaaa片日本免费| 亚洲av一区综合| 国产 一区精品| 亚洲精品一卡2卡三卡4卡5卡| 亚洲人成网站在线播| 午夜老司机福利剧场| 黑人高潮一二区| 在线观看66精品国产| 国产av一区在线观看免费| 美女cb高潮喷水在线观看| 五月伊人婷婷丁香| 人妻夜夜爽99麻豆av| 人妻久久中文字幕网| 最近在线观看免费完整版| 有码 亚洲区| 午夜福利高清视频| 亚洲高清免费不卡视频| 亚洲国产精品sss在线观看| 国产成人精品久久久久久| 亚洲国产日韩欧美精品在线观看| 级片在线观看| 一级黄片播放器| 欧美成人一区二区免费高清观看| 嫩草影院精品99| 日本精品一区二区三区蜜桃| 日韩中字成人| av在线观看视频网站免费| 精品一区二区三区人妻视频| 伦理电影大哥的女人| 亚洲性久久影院| 日韩一区二区视频免费看| 成年av动漫网址| 国产亚洲欧美98| 人妻少妇偷人精品九色| 插阴视频在线观看视频| 免费观看人在逋| 有码 亚洲区| 国产私拍福利视频在线观看| eeuss影院久久| av中文乱码字幕在线| 身体一侧抽搐| 欧美日韩综合久久久久久| 日韩,欧美,国产一区二区三区 | 午夜a级毛片| 国产三级在线视频| 久久久久久九九精品二区国产| 在线观看66精品国产| 亚洲精华国产精华液的使用体验 | 中文字幕久久专区| 精品国内亚洲2022精品成人| 免费看日本二区| 日本撒尿小便嘘嘘汇集6| 日韩亚洲欧美综合| 一边摸一边抽搐一进一小说| 狠狠狠狠99中文字幕| 听说在线观看完整版免费高清| 国产私拍福利视频在线观看| 3wmmmm亚洲av在线观看| 日日啪夜夜撸| 久久精品人妻少妇| 国产精品一区二区性色av| 精品不卡国产一区二区三区| 国产精品一区二区三区四区免费观看 | 黄色配什么色好看| 国产精品不卡视频一区二区| 看片在线看免费视频| 日本一本二区三区精品| 亚洲不卡免费看| 99热这里只有精品一区| 一级av片app| 免费在线观看成人毛片| 热99re8久久精品国产| 别揉我奶头~嗯~啊~动态视频| 美女cb高潮喷水在线观看| 性插视频无遮挡在线免费观看| 日本a在线网址| 男女之事视频高清在线观看| 18禁在线播放成人免费| or卡值多少钱| 成年女人永久免费观看视频| av免费在线看不卡| 国产成人91sexporn| 一区福利在线观看| 精品久久久久久久久亚洲| 97人妻精品一区二区三区麻豆| 亚洲激情五月婷婷啪啪| 国内少妇人妻偷人精品xxx网站| 国产白丝娇喘喷水9色精品| 久久鲁丝午夜福利片| 在线国产一区二区在线| 久久久a久久爽久久v久久| 精品日产1卡2卡| 麻豆成人午夜福利视频| 禁无遮挡网站| 嫩草影院入口| 亚洲av熟女| 免费观看人在逋| 久久久久久伊人网av| 少妇被粗大猛烈的视频| 三级经典国产精品| 小蜜桃在线观看免费完整版高清| av黄色大香蕉| 精品日产1卡2卡| 最近的中文字幕免费完整| 熟女人妻精品中文字幕| 国产淫片久久久久久久久| 给我免费播放毛片高清在线观看| 久久久久九九精品影院| 欧美xxxx黑人xx丫x性爽| 一区二区三区免费毛片| 亚洲五月天丁香| 中国美女看黄片| 亚洲国产精品成人综合色| а√天堂www在线а√下载| 午夜亚洲福利在线播放| 亚洲av一区综合| 亚洲av第一区精品v没综合| 狠狠狠狠99中文字幕| 岛国在线免费视频观看| 观看美女的网站| а√天堂www在线а√下载| 91在线精品国自产拍蜜月| 岛国在线免费视频观看| 久久6这里有精品| av视频在线观看入口| 天美传媒精品一区二区| а√天堂www在线а√下载| 亚洲欧美日韩卡通动漫| 日韩成人av中文字幕在线观看 | 精品一区二区三区av网在线观看| 老女人水多毛片| 日韩大尺度精品在线看网址| 一级毛片aaaaaa免费看小| 国产欧美日韩精品一区二区| 国产伦精品一区二区三区四那| 亚洲丝袜综合中文字幕| 麻豆一二三区av精品| 欧美日本视频| 欧美人与善性xxx| 日本熟妇午夜| 白带黄色成豆腐渣| 欧美日韩综合久久久久久| 国产精品久久久久久久电影| 夜夜看夜夜爽夜夜摸| 九九在线视频观看精品| .国产精品久久| 日韩欧美精品v在线| 亚洲色图av天堂| 一个人看的www免费观看视频| 99久久九九国产精品国产免费| 99久久九九国产精品国产免费| 成年版毛片免费区| av福利片在线观看| 夜夜看夜夜爽夜夜摸| 日本-黄色视频高清免费观看| 精品一区二区三区视频在线观看免费| 夜夜看夜夜爽夜夜摸| 国内少妇人妻偷人精品xxx网站| av天堂在线播放| 国产真实伦视频高清在线观看| 精品久久久久久久久亚洲| avwww免费| 久久久久久伊人网av| 亚洲自偷自拍三级| 有码 亚洲区| 乱人视频在线观看| 日本爱情动作片www.在线观看 | 午夜视频国产福利| 精品久久久久久久人妻蜜臀av| 天堂av国产一区二区熟女人妻| 国产在线男女| 在线播放无遮挡| 亚洲激情五月婷婷啪啪| 97人妻精品一区二区三区麻豆| 国产黄a三级三级三级人| 美女xxoo啪啪120秒动态图| 日日摸夜夜添夜夜爱| 一边摸一边抽搐一进一小说| 亚洲欧美清纯卡通| 一本久久中文字幕| 久99久视频精品免费| 干丝袜人妻中文字幕| 精品久久久久久成人av| 最近最新中文字幕大全电影3| 亚洲在线观看片| 国产午夜精品论理片| 亚洲色图av天堂| 1000部很黄的大片| 欧美又色又爽又黄视频| 最新中文字幕久久久久| 国产一区亚洲一区在线观看| 噜噜噜噜噜久久久久久91| 日本免费a在线| 插阴视频在线观看视频| 国产真实乱freesex| 桃色一区二区三区在线观看| 久久久久久久久久久丰满| 午夜精品一区二区三区免费看| 久久久久久久久中文| 国内精品一区二区在线观看| 国产视频一区二区在线看| 成人av一区二区三区在线看| 丝袜喷水一区| 久久久欧美国产精品| 黄色一级大片看看| 免费av不卡在线播放| 在线观看免费视频日本深夜| 精品不卡国产一区二区三区| 亚洲av中文av极速乱| 男女下面进入的视频免费午夜| 自拍偷自拍亚洲精品老妇| 成人三级黄色视频| 99久久中文字幕三级久久日本| 国国产精品蜜臀av免费| 一区二区三区四区激情视频 | 91在线精品国自产拍蜜月| 久久午夜亚洲精品久久| 最新在线观看一区二区三区| 在线播放国产精品三级| 人人妻人人看人人澡| 成人亚洲欧美一区二区av| 国产精品一区二区性色av| 欧美日韩精品成人综合77777| 亚洲国产欧洲综合997久久,| 精品免费久久久久久久清纯| 毛片一级片免费看久久久久| 简卡轻食公司| 亚洲图色成人| 国产激情偷乱视频一区二区| 黄色一级大片看看| 国产精品综合久久久久久久免费| 日韩精品有码人妻一区| 国产一区二区亚洲精品在线观看| 亚洲高清免费不卡视频| 免费在线观看成人毛片| 中文在线观看免费www的网站| 国产精品人妻久久久久久| 国产精品亚洲一级av第二区| 人人妻人人澡欧美一区二区| 精品乱码久久久久久99久播| 欧美日韩乱码在线| av女优亚洲男人天堂| 内地一区二区视频在线| 赤兔流量卡办理| 中文亚洲av片在线观看爽| 国产真实伦视频高清在线观看| 国产高清视频在线观看网站| 成人午夜高清在线视频| 可以在线观看的亚洲视频| 国产精品久久电影中文字幕| 欧美高清成人免费视频www| 在线观看免费视频日本深夜| 村上凉子中文字幕在线| 十八禁网站免费在线| 久久午夜福利片| 国产精品一区二区免费欧美| 亚洲国产日韩欧美精品在线观看| 国产老妇女一区| 日本色播在线视频| 少妇的逼好多水| 在线观看午夜福利视频| 国产精品伦人一区二区| 亚洲av中文字字幕乱码综合| 欧美日韩综合久久久久久| 搡老岳熟女国产| a级毛片免费高清观看在线播放| 国产成人影院久久av| 欧美成人免费av一区二区三区| 成人精品一区二区免费| av福利片在线观看| 国内精品美女久久久久久| 一进一出抽搐gif免费好疼| 自拍偷自拍亚洲精品老妇| 国产 一区精品| 成年女人永久免费观看视频| 国模一区二区三区四区视频| 最新在线观看一区二区三区| 亚洲欧美日韩高清在线视频| 人人妻,人人澡人人爽秒播| 男女之事视频高清在线观看| 人妻少妇偷人精品九色| 波多野结衣巨乳人妻| 国产av在哪里看| 偷拍熟女少妇极品色| 成人二区视频| 精品福利观看| 丰满的人妻完整版| 国产真实乱freesex| 18+在线观看网站| 亚洲国产精品sss在线观看| 欧美激情在线99| 尤物成人国产欧美一区二区三区| 国产精品1区2区在线观看.| 精品国产三级普通话版| 国产精品久久久久久av不卡| 欧美中文日本在线观看视频| 亚洲欧美日韩高清在线视频| 欧美激情久久久久久爽电影| 此物有八面人人有两片| АⅤ资源中文在线天堂| videossex国产| 99热这里只有精品一区| 国产精品不卡视频一区二区| 在线观看av片永久免费下载| 亚洲精品色激情综合| 国产精品久久久久久av不卡| 日本黄色片子视频| 久久久欧美国产精品| 两个人的视频大全免费| www.色视频.com| 最近中文字幕高清免费大全6| 非洲黑人性xxxx精品又粗又长| 久久久精品大字幕| av天堂中文字幕网| 国产不卡一卡二| 国产精品精品国产色婷婷| 国产麻豆成人av免费视频| 青春草视频在线免费观看| 三级男女做爰猛烈吃奶摸视频| 久久国产乱子免费精品| 国产一区二区三区在线臀色熟女| 能在线免费观看的黄片| 欧美色视频一区免费| 老师上课跳d突然被开到最大视频| 在线国产一区二区在线| 国产女主播在线喷水免费视频网站 | 免费av观看视频| 此物有八面人人有两片| 欧美一区二区国产精品久久精品| 人妻少妇偷人精品九色| 国产av麻豆久久久久久久| 99久久久亚洲精品蜜臀av| 国产国拍精品亚洲av在线观看| 男人和女人高潮做爰伦理| 国产在线精品亚洲第一网站| 九九在线视频观看精品| 久久精品国产清高在天天线| 最后的刺客免费高清国语| 亚洲国产精品国产精品| 变态另类成人亚洲欧美熟女| 国产蜜桃级精品一区二区三区| 亚洲五月天丁香| 亚洲图色成人| av福利片在线观看| 一进一出好大好爽视频| 久久天躁狠狠躁夜夜2o2o| 国产乱人偷精品视频| 99视频精品全部免费 在线| 色吧在线观看| 久久午夜亚洲精品久久| 中文字幕久久专区| 成人av一区二区三区在线看| 床上黄色一级片| 热99re8久久精品国产| 91在线观看av| 无遮挡黄片免费观看| 搡老妇女老女人老熟妇| 成人亚洲精品av一区二区| 网址你懂的国产日韩在线| 菩萨蛮人人尽说江南好唐韦庄 | 九九爱精品视频在线观看| h日本视频在线播放| 亚洲av.av天堂| 在现免费观看毛片| 国产探花在线观看一区二区| 22中文网久久字幕| 中文字幕熟女人妻在线| 又爽又黄无遮挡网站| 亚洲国产精品合色在线| 久久精品国产亚洲av香蕉五月| 日韩高清综合在线| 亚洲av成人精品一区久久| 亚洲一区二区三区色噜噜| 成年女人永久免费观看视频| 狂野欧美白嫩少妇大欣赏| 亚洲成av人片在线播放无| 国产午夜精品久久久久久一区二区三区 | 高清日韩中文字幕在线| 午夜激情欧美在线| 伦精品一区二区三区| 国产一区二区三区av在线 | 国产欧美日韩精品亚洲av| 能在线免费观看的黄片| 日韩一区二区视频免费看| 日本免费一区二区三区高清不卡| 女生性感内裤真人,穿戴方法视频| 最近的中文字幕免费完整| 欧美激情国产日韩精品一区| 一a级毛片在线观看| 夜夜爽天天搞| 丝袜喷水一区| 欧美xxxx性猛交bbbb| 18+在线观看网站| 亚洲自拍偷在线| av卡一久久| 十八禁国产超污无遮挡网站| 日本黄大片高清| or卡值多少钱| 如何舔出高潮| 少妇熟女aⅴ在线视频| 美女黄网站色视频| 日韩 亚洲 欧美在线| 亚洲,欧美,日韩| 久久精品夜夜夜夜夜久久蜜豆| 久久久久国内视频| 精品久久久久久久久久免费视频| 国内少妇人妻偷人精品xxx网站| 久久综合国产亚洲精品| 国产精品久久电影中文字幕| 久久精品91蜜桃| 91久久精品国产一区二区三区| 女人被狂操c到高潮| 免费av不卡在线播放| 国产av不卡久久| 啦啦啦啦在线视频资源| 网址你懂的国产日韩在线| 我的女老师完整版在线观看| 在线免费十八禁| 国产午夜精品论理片| 热99在线观看视频| 麻豆国产av国片精品| 搡老熟女国产l中国老女人| 欧美bdsm另类| 男人的好看免费观看在线视频| 看片在线看免费视频| 97人妻精品一区二区三区麻豆| 亚洲五月天丁香| 黄色欧美视频在线观看| 国产精品福利在线免费观看| 99久久无色码亚洲精品果冻| 午夜精品一区二区三区免费看| 久久欧美精品欧美久久欧美| 毛片一级片免费看久久久久| 国内精品久久久久精免费| 亚洲乱码一区二区免费版| 色播亚洲综合网| 久久久精品大字幕| 久久人人精品亚洲av| 久久午夜福利片| 赤兔流量卡办理| 国产 一区精品| 久久久久九九精品影院| 精品欧美国产一区二区三| 成人一区二区视频在线观看| 国产一区二区在线观看日韩| 毛片女人毛片| 欧美绝顶高潮抽搐喷水| 久久精品国产清高在天天线| 狂野欧美白嫩少妇大欣赏| 黄色一级大片看看| 国产av不卡久久| 特大巨黑吊av在线直播| 亚洲电影在线观看av| 一级毛片久久久久久久久女| 尤物成人国产欧美一区二区三区| 天天躁夜夜躁狠狠久久av| 卡戴珊不雅视频在线播放| 99精品在免费线老司机午夜| 国产一区二区三区av在线 | 俄罗斯特黄特色一大片| 日本三级黄在线观看| 波多野结衣高清无吗| 六月丁香七月| 在线国产一区二区在线| 日韩欧美三级三区| 啦啦啦啦在线视频资源| 久久精品91蜜桃| 欧美日韩乱码在线| 丝袜喷水一区| av在线观看视频网站免费| 亚洲欧美清纯卡通| 特级一级黄色大片| 亚洲av美国av| 国产成人影院久久av| av专区在线播放| 欧美bdsm另类| 国产精品久久久久久av不卡| 日韩大尺度精品在线看网址| 黄片wwwwww| 久久精品夜色国产| .国产精品久久| 噜噜噜噜噜久久久久久91| 观看免费一级毛片| 久久国产乱子免费精品| 国产真实乱freesex| 在线a可以看的网站| 99久久中文字幕三级久久日本| 99热全是精品| 日本黄大片高清| 亚洲精品影视一区二区三区av| 亚洲国产日韩欧美精品在线观看| 哪里可以看免费的av片| 级片在线观看| 久久精品久久久久久噜噜老黄 | 永久网站在线| 成人无遮挡网站| 看十八女毛片水多多多| 亚洲av第一区精品v没综合| 欧美日本视频| 国产精品爽爽va在线观看网站| 联通29元200g的流量卡| 丰满人妻一区二区三区视频av| 亚洲图色成人| 在线观看一区二区三区| 久久草成人影院| 无遮挡黄片免费观看| 国产日本99.免费观看| 97碰自拍视频| 国产美女午夜福利| 精品熟女少妇av免费看| 欧美xxxx黑人xx丫x性爽| 成年版毛片免费区| 一区二区三区四区激情视频 | 赤兔流量卡办理| 精品久久国产蜜桃| 97超碰精品成人国产| 十八禁网站免费在线| 中文在线观看免费www的网站| 我的女老师完整版在线观看| 欧美最黄视频在线播放免费| a级毛片a级免费在线| 精品少妇黑人巨大在线播放 | 国产精品福利在线免费观看| 久久99热6这里只有精品| 日韩精品青青久久久久久| 国产精品美女特级片免费视频播放器| 国产熟女欧美一区二区| 在线观看午夜福利视频| 不卡视频在线观看欧美| 哪里可以看免费的av片| 中出人妻视频一区二区| 久久久久国产网址| 男女边吃奶边做爰视频| 中文字幕久久专区| 成人三级黄色视频| 国产精品久久久久久av不卡| 两性午夜刺激爽爽歪歪视频在线观看| 国产精品久久久久久精品电影| 国产美女午夜福利| 久久草成人影院| 三级国产精品欧美在线观看| 99久久精品国产国产毛片| 午夜日韩欧美国产| 久久精品夜夜夜夜夜久久蜜豆| 女的被弄到高潮叫床怎么办| 麻豆久久精品国产亚洲av| 美女黄网站色视频| 中文字幕人妻熟人妻熟丝袜美| 此物有八面人人有两片| 97热精品久久久久久| 变态另类成人亚洲欧美熟女| or卡值多少钱| 男人狂女人下面高潮的视频| 国产午夜精品久久久久久一区二区三区 | 精品久久久噜噜| 国产精品1区2区在线观看.| 最近视频中文字幕2019在线8| 国产精品一二三区在线看|